-
-
-
-
-
-
-
Lumos Pharma Announces Retirement of Carl Langren and Names Lori Lawley Chief Financial Officer in Planned Succession
-
-
-
-
-
-
-
Lumos Pharma, Inc. (LUMO) Sells Priority Review Voucher (PRV) to Merck at $100M Valuation
-
-
-
-
-
-
922,394 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All